Explore the full directors' dealings record of Amcor plc, a listed equity based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Operating in the Chemicals & Materials sector, Amcor plc has published 94 public disclosures. Market capitalisation: €19bn. The latest transaction was filed on 2 June 2022 — Cession. Among the most active insiders: Zacka Michael J. All data is openly available.
25 of 94 declarations
Amcor plc is a global packaging leader serving consumer, food, beverage and healthcare markets. The company is listed in the United States on the NYSE under the ticker AMCR, which makes it directly relevant for investors tracking SEC filings, including Form 4 insider transactions. Amcor is headquartered operationally in Zurich, Switzerland, while its industrial footprint and customer base span North America, Europe, Asia-Pacific and emerging markets. Its competitive appeal comes from scale, technical expertise, close customer relationships and a long-running focus on packaging solutions that are lighter, more efficient and more recyclable. ([amcor.com](https://www.amcor.com/media/news/amcor-completes-one-for-five-reverse-stock-split?utm_source=openai)) From a business-model perspective, Amcor’s roots go back to its historic packaging and paper heritage, but the modern company has been reshaped through decades of industrial consolidation and portfolio expansion. Today it positions itself as a responsible packaging specialist with two core platforms: flexible packaging and rigid packaging, plus specialized solutions for healthcare and pharmaceuticals. That mix gives the group exposure to relatively defensive end markets where packaging is a mission-critical, recurring spend item. Amcor’s public positioning emphasizes innovation, global manufacturing reach and application-specific packaging science rather than commodity packaging alone. ([amcor.com](https://www.amcor.com/about?utm_source=openai)) Its product range is broad. In flexible packaging, Amcor supplies films, pouches, wraps and high-barrier structures for food, beverages, home and personal care, pet care and technical applications. In rigid packaging, it offers bottles, jars, containers, closures, cups, trays and related systems. In healthcare, the company develops sterile barrier systems, thermoformed packaging and recycle-ready solutions for medical and pharmaceutical customers. Amcor also highlights branded sustainable platforms such as AmPrima™, AmLite, AmFiber™ and AmSky®, which are designed to improve recyclability, reduce material use or replace harder-to-recycle structures. ([amcor.com](https://www.amcor.com/products?utm_source=openai)) In competitive terms, Amcor’s moat is built on scale, technical service and the ability to embed itself in customers’ supply chains across geographies and categories. The company’s recent news flow has been dominated by strategic execution and industrial investment. In January 2026, Amcor completed a 1-for-5 reverse stock split on the NYSE. During 2025, it announced North American capacity investments, including a major protein-packaging expansion and upgrades to post-consumer recycled packaging capability. It also continued to advance the integration/combination with Berry Global, a transaction expected to strengthen its portfolio and especially its polyethylene shrink capabilities. ([amcor.com](https://www.amcor.com/media/news/amcor-completes-one-for-five-reverse-stock-split?utm_source=openai))